ABBVIE INC
ABBVNYSE🏆 #25 by market capEarnings Oct 30 · PreUS Equity
$286.35▼ $0.03 (−0.01%)
🌙 After hours$287.85▲ 0.52%Regular close · extended-hours price shownTrack ABBV
Get earnings, price moves & breaking news on Telegram
24h▼ 0.0%
7d▲ 0.6%
14d▲ 1.0%
30d▲ 7.5%
ytd▲ 25.3%
1y▲ 25.8%
🏦Market Cap
$506.01B
Large Cap
📈Revenue Growth (YoY)
10.4%
Healthy
📊Gross Margin
72.8%
High
💵FCF Margin
28.3%
Strong
⚖️P/S Ratio
7.8x
Fair
Otter Score
76
Strong
ABBVIE INC
ABBVAnalyst Ratings
Price
$286.35
Total
44
Raised
5
Lowered
6
Avg PT
$294.00
H / L
$325 / $235
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Goldman Sachs | Reiterated | Neutral | 2026-10-23 | $294.00 | +2.70% |
Barclays | Reiterated | Overweight | 2026-10-21 | $325.00 | +13.50% |
RBC Capital | Reiterated | Outperform | 2026-10-13 | $280.00 | −2.20% |
Guggenheim | Reiterated | Buy | 2026-10-09 | $288.00 | +0.60% |
UBS | Reiterated | Neutral | 2026-10-09 | $260.00 | −9.20% |
Cantor Fitzgerald | Reiterated | Overweight | 2026-10-08 | $290.00 | +1.30% |
JP Morgan | Reiterated | Overweight | 2026-10-08 | $180.00 | −37.10% |
Morgan Stanley | Reiterated | Overweight | 2026-10-07 | $310.00 | +8.30% |
Scotiabank | Reiterated | Sector Outperform | 2026-10-06 | $320.00 | +11.80% |
HSBC | Reiterated | Buy | 2026-09-10 | $315.00 | +10.00% |
Piper Sandler | Reiterated | Overweight | 2026-08-20 | $303.00 | +5.80% |
Wells Fargo | Reiterated | Overweight | 2026-08-17 | $300.00 | +4.80% |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2026-08-13 | $300.00 | +4.80% |
BNP Paribas | Reiterated | Neutral | 2026-08-11 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2026-08-10 | — | — |
Berenberg | Reiterated | Buy | 2026-08-06 | — | — |
Erste Group | Upgraded | Hold → Buy | 2026-08-05 | — | — |
Canaccord Genuity | Reiterated | Buy | 2026-08-03 | $290.00 | +1.30% |
William Blair | Reiterated | Buy | 2026-07-31 | $190.00 | −33.60% |
TD Cowen | Reiterated | Buy | 2026-07-31 | — | — |
Citigroup | Reiterated | Neutral | 2026-07-15 | $226.00 | −21.10% |
BMO Capital | Reiterated | Outperform | 2026-07-13 | $300.00 | +4.80% |
B of A Securities | Reiterated | Buy | 2026-07-10 | — | — |
Freedom Broker | Reiterated | Buy | 2026-02-17 | — | — |
Raymond James | Reiterated | Outperform | 2025-10-17 | $256.00 | −10.60% |
Truist Securities | Reiterated | Buy | 2025-02-03 | — | — |
Leerink Partners | Upgraded | Market Perform → Outperform | 2024-11-22 | $135.00 | −52.90% |
Argus Research | Upgraded | Hold → Buy | 2024-11-04 | $155.00 | −45.90% |
CFRA | Downgraded | Buy → Hold | 2023-03-29 | — | — |
SVB Leerink | Upgraded | Underperform → Market Perform | 2023-02-10 | — | — |
Atlantic Equities | Reiterated | Neutral | 2023-02-10 | — | — |
Societe Generale | Downgraded | Buy → Hold | 2022-11-08 | $172.00 | −39.90% |
Mizuho | Reiterated | Buy | 2022-02-04 | — | — |
Bernstein | Reiterated | Outperform | 2022-01-03 | $203.00 | −29.10% |
Cowen & Co. | Reiterated | Outperform | 2020-02-18 | $150.00 | −47.60% |
Citi | Reiterated | Buy | 2019-11-20 | — | — |
Piper Jaffray | Reiterated | Overweight | 2019-09-04 | — | — |
Bank of America | Downgraded | Buy → Neutral | 2019-01-03 | — | — |
Argus | Reiterated | Buy | 2018-11-06 | — | — |
PiperJaffray | Downgraded | Overweight → Neutral | 2018-06-01 | — | — |
Credit Suisse | Downgraded | Neutral → Underperform | 2018-05-30 | $170.00 | −40.60% |
Leerink Swann | Downgraded | Outperform → Market Perform | 2018-01-29 | — | — |
Jefferies | Reiterated | Buy | 2017-09-15 | — | — |
Deutsche Bank | Reiterated | Hold | 2017-07-17 | $175.00 | −38.90% |
Institution
Goldman Sachs
Reiterated · Neutral · 2026-10-23
$294.00
+2.70%
Barclays
Reiterated · Overweight · 2026-10-21
$325.00
+13.50%
RBC Capital
Reiterated · Outperform · 2026-10-13
$280.00
−2.20%
Guggenheim
Reiterated · Buy · 2026-10-09
$288.00
+0.60%
UBS
Reiterated · Neutral · 2026-10-09
$260.00
−9.20%
Cantor Fitzgerald
Reiterated · Overweight · 2026-10-08
$290.00
+1.30%
JP Morgan
Reiterated · Overweight · 2026-10-08
$180.00
−37.10%
Morgan Stanley
Reiterated · Overweight · 2026-10-07
$310.00
+8.30%
Scotiabank
Reiterated · Sector Outperform · 2026-10-06
$320.00
+11.80%
HSBC
Reiterated · Buy · 2026-09-10
$315.00
+10.00%
Piper Sandler
Reiterated · Overweight · 2026-08-20
$303.00
+5.80%
Wells Fargo
Reiterated · Overweight · 2026-08-17
$300.00
+4.80%
Wolfe Research
Upgraded · Peer Perform → Outperform · 2026-08-13
$300.00
+4.80%
BNP Paribas
Reiterated · Neutral · 2026-08-11
—
—
Evercore ISI Group
Reiterated · Outperform · 2026-08-10
—
—
Berenberg
Reiterated · Buy · 2026-08-06
—
—
Erste Group
Upgraded · Hold → Buy · 2026-08-05
—
—
Canaccord Genuity
Reiterated · Buy · 2026-08-03
$290.00
+1.30%
William Blair
Reiterated · Buy · 2026-07-31
$190.00
−33.60%
TD Cowen
Reiterated · Buy · 2026-07-31
—
—
Citigroup
Reiterated · Neutral · 2026-07-15
$226.00
−21.10%
BMO Capital
Reiterated · Outperform · 2026-07-13
$300.00
+4.80%
B of A Securities
Reiterated · Buy · 2026-07-10
—
—
Freedom Broker
Reiterated · Buy · 2026-02-17
—
—
Raymond James
Reiterated · Outperform · 2025-10-17
$256.00
−10.60%
Truist Securities
Reiterated · Buy · 2025-02-03
—
—
Leerink Partners
Upgraded · Market Perform → Outperform · 2024-11-22
$135.00
−52.90%
Argus Research
Upgraded · Hold → Buy · 2024-11-04
$155.00
−45.90%
CFRA
Downgraded · Buy → Hold · 2023-03-29
—
—
SVB Leerink
Upgraded · Underperform → Market Perform · 2023-02-10
—
—
Atlantic Equities
Reiterated · Neutral · 2023-02-10
—
—
Societe Generale
Downgraded · Buy → Hold · 2022-11-08
$172.00
−39.90%
Mizuho
Reiterated · Buy · 2022-02-04
—
—
Bernstein
Reiterated · Outperform · 2022-01-03
$203.00
−29.10%
Cowen & Co.
Reiterated · Outperform · 2020-02-18
$150.00
−47.60%
Citi
Reiterated · Buy · 2019-11-20
—
—
Piper Jaffray
Reiterated · Overweight · 2019-09-04
—
—
Bank of America
Downgraded · Buy → Neutral · 2019-01-03
—
—
Argus
Reiterated · Buy · 2018-11-06
—
—
PiperJaffray
Downgraded · Overweight → Neutral · 2018-06-01
—
—
Credit Suisse
Downgraded · Neutral → Underperform · 2018-05-30
$170.00
−40.60%
Leerink Swann
Downgraded · Outperform → Market Perform · 2018-01-29
—
—
Jefferies
Reiterated · Buy · 2017-09-15
—
—
Deutsche Bank
Reiterated · Hold · 2017-07-17
$175.00
−38.90%
One row per institution · price target from the firm's latest published target